Focal Healthcare’s Prostate Fusion Biopsy Solution Gains CE Mark

Focal Healthcare has received the CE Mark for its Fusion Bx 2.0, a semi-robotic prostate fusion biopsy solution that enables urologists to perform targeted prostate biopsies.

The system uses a simple interface and comes with a semi-robotic arm used to maintain probe steadiness during biopsies. It also displays a 3D model for prostate and MRI target visualization in real-time.

The Fusion Bx 2.0 features automatic motion compensation to account for patient movement, maintaining imaging and allowing procedures to continue uninterrupted.